TIAs: carotid …

Seemant Chaturvedi MD

Stroke & Vascular Disorders

Updated 02.26.2024
Released 09.15.1994
Expires For CME 02.26.2027

TIAs (carotid)

Author: Seemant Chaturvedi MD

See Contributor Disclosures

Editor: Steven R Levine MD

TIAs (carotid)

In This Article

Quick Link

Introduction

Overview

The author provides an update on carotid transient ischemic attacks, with descriptions of new studies pertaining to antiplatelet therapy and transient ischemic attack prognosis. New imaging and treatment methods for carotid plaques are also discussed.

Key points

	• Transient ischemic attacks are an important warning sign for stroke and deserve rapid evaluation and treatment.
	• Risk stratification schemes can be useful for identifying the highest risk transient ischemic attack patients.
	• Patients with transient ischemic attacks should receive rapid medical therapy (antithrombotic therapy for all, antihypertensives and statins for most) and carotid revascularization in select subjects.
	• Short-term dual antiplatelet therapy is now recommended for high-risk patients with transient ischemic attacks.

Historical note and terminology

In 1951, Fisher described seven patients with internal carotid artery occlusion and transient or permanent ischemic symptoms using the words "brief transient attacks of paralysis" (22). In a separate publication that same year, Fisher linked occlusive disease at the internal carotid artery bifurcation to "transient episodes of blindness, aphasia, paresthesia and paralysis," "transient attacks," "premonitory fleeting," and "transient hemiplegia" (21). Fisher went on to credit many other investigators who, earlier in this century, identified similar symptoms in relation to internal carotid artery bifurcation disease. He was unsure about the mechanism of symptom production and speculated about the roles of thrombosis, vasospasm, and embolism.

This review addresses all transient ischemic attacks in the territory of the internal carotid artery or its branches: the ophthalmic artery, posterior communicating artery, anterior choroidal artery, anterior cerebral artery, and middle cerebral artery (52). The discussion will not be limited to carotid territory transient ischemic attacks that are due solely to occlusive disease at the internal carotid artery bifurcation.

Clinical manifestations

Presentation and course

The diagnosis of transient ischemic attacks is subjective, as only 10% of spells are actually witnessed by the diagnosing physician (20; 28). The kappa value for interobserver agreement on the diagnosis of transient ischemic attack is only 0.65 (28).

A transient ischemic attack is defined as an acute focal neurologic deficit that is localized to one vascular territory, lasting less than 24 hours, with abrupt onset and abrupt or gradual resolution. Because the symptoms may be frightening, the history may be unreliable. Fully 40% of transient ischemic attacks last more than one hour, and 90% last less than 6 hours, despite the common description that they usually last only minutes in duration. The mean duration is 3 to 6 hours if patients are examined during a spell. The severity of symptoms varies from very mild to extreme, and the frequency may vary from a solitary attack to many per day over a period of years (20).

Symptoms of left carotid transient ischemic attack include transient dysarthria, right limb weakness, right face weakness, left eye or right field visual impairment, dysphasia, and right body or face numbness or paresthesia. Right carotid transient ischemic attacks produce similar symptoms on the left side of the body, but dysphasia is rare (20).

Transient ischemic attacks of the eye, also known as amaurosis fugax or transient monocular blindness, are described by patients as a unilateral fog, blur, cloud, mist, shade, or curtain (52). A shade or curtain is no more predictive of carotid artery disease than are the other symptoms, any of which usually lasts less than 10 to 15 minutes. About one fourth of all patients with transient ischemic attacks complain of headache during the spell.

Atypical carotid transient ischemic attacks include transient monocular blindness occurring only after exposure to bright light, limb shaking, orthostatic transient ischemic attacks, transient anosognosia, and transient loss of pitch perception (20).

One third of patients who report "transient ischemic attacks" and are then examined during an attack are believed by their physicians to have not had a transient ischemic attack. Patients who complain of a single symptom often exhibit other signs on examination. Language and motor deficits are common, but sensory deficits during a spell are rare. Visual field deficits, when detected, are typically unnoticed by the patient (20). During a spell of transient monocular blindness, retinal vessels typically appear normal, but this does not mean that ischemia is not present. The careful examiner may see white or grayish material, presumably platelet complexes, in retinal vessels, but it is rare to see a patient during an attack. A careful ophthalmologic examination can be crucial to the diagnosis of transient monocular blindness: narrow anterior chamber angle suggests recurrent angle-closure as the cause of symptoms, rather than ischemia; conjunctivitis, uveitis, and scleritis suggest vasculitis; papilledema suggests intracranial hypertension; and one swollen disc suggests ischemia, inflammation, or infiltration. Cotton wool and Roth spots suggest arteritis or blood dyscrasia, whereas a pale swollen disc suggests inflammation or lipohyalinotic ischemia of the optic disc.

A carotid bifurcation bruit is heard in about two thirds of transient ischemic attack patients with severe ipsilateral carotid stenosis. These patients may have enhanced facial artery pulses due to collateral flow downstream from severe internal carotid artery bifurcation disease (10).

Prognosis and complications

The outcome of carotid transient ischemic attack is believed to be more likely benign in young patients with frequent episodes, a prolonged course, and no severe cardioembolic or carotid disease (54). Yet, many patients with transient ischemic attack have an impaired quality of life and occupational status, with fatigue or memory problems even if a stroke did not occur (20). Observation suggests that the risk of stroke is highest soon after the first event or with multiple transient ischemic attacks.

The stroke risk varies according to the etiology of the initial event. In a 5-year follow-up of 3847 patients from 21 countries after an initial transient ischemic attack diagnosis, the rate of stroke was 9.5%, with about half of the events occurring in the first year and half during years 2 to 5 (03). During the 5-year period, rates of death from any cause, death from vascular causes, and major bleeding were 10.6%, 2.7%, and 1.5%, respectively. Individuals with index transient ischemic attack due to large artery atherosclerosis or cerebral embolism were at higher risk. Patients with an elevated ABCD2 score of 4 or higher were also at higher stroke risk. Retinal infarction after transient monocular blindness, presumably due to retinal branch or central retinal artery occlusion, is uncommon (48).

In the North American Symptomatic Carotid Endarterectomy Trial, in which patients with carotid stenosis and transient ischemic attack or minor stroke were studied, the stroke risk in patients with transient visual loss was approximately half that of patients with hemispheric transient ischemic attack (hazard ratio 0.53) (06). There was a 14.3% risk reduction with endarterectomy in patients with at least three of the following risk factors: (1) age of 75 years or more, (2) male sex, (3) history of hemispheric transient ischemic stroke or stroke, (4) history of intermittent claudication, (5) 80% to 94% angiographic stenosis, and (6) absence of collateral circulation.

In a study that did not preselect patients with carotid stenosis, it was found that the presence of age greater than 65 years, diabetes, hypertension, coronary disease, and stroke rather than transient ischemic attack as a first symptom dramatically increased the stroke and death rate at two years from 10% to 59% (40).

A study of patients seen in the emergency room who were given a diagnosis of transient ischemic attack found that the short-term outlook was slightly worse than earlier reports. In this analysis of 1707 patients, there was a 10.5% incidence of stroke at 90 days, with half of the strokes occurring in the first two days (35). Age greater than 60 years, diabetes, symptom duration of greater than 10 minutes, weakness, and speech impairment were associated with a higher risk. A Canadian study that followed 2285 patients diagnosed in the emergency room with a transient ischemic attack in the province of Alberta identified a similar 90-day rate of stroke of 9.5% (30). In this study, the 1-year stroke risk was 14.5%, and hypertension, diabetes, and older age were predictors of increased stroke risk at one year. In more modern studies, such as the TIA.org Registry, the 1-year stroke risk is now lower due to widespread use of more intensive medical therapy.

The short-term risk of stroke can be reduced with rapid evaluation and institution of treatment with antiplatelet agents, statins, and antihypertensives (61). In the Oxford Vascular Study, patients referred to a rapid evaluation stroke and TIA clinic had a 2.1% risk of stroke at 90 days, compared to a 10.3% risk with the “standard” evaluation system (p=0.0001). For patients with symptomatic carotid stenosis, modern medical therapy appears to be associated with a reduction in the stroke rate. In a study of 397 patients with symptomatic carotid stenosis, the 30-day risk of stroke was 7.5% (66).

Even in patients with a non-recent transient ischemic attack, there is an increased risk of stroke and cardiac events. In an analysis of patients from the Oxford community stroke project who had a transient ischemic attack at a median of 3.8 years previously, there was a 18.8% risk of stroke over 10 years and a 27.8% risk of myocardial infarction or cardiac death over 10 years (15).

A simple scoring system can help clinicians identify patients at increased risk for stroke following transient ischemic attack. The ABCD acronym signifies A (age of greater than 60 years), B (blood pressure greater than 140/90), C (clinical features: unilateral weakness, speech disturbance), and D (duration of symptoms in minutes). In the Oxford Vascular Study, the seven-day risk of stroke was 0.4% in patients with a score of less than 5, 12.1% in patients with a score of 5, and 31.4% in patients with a score of 6 (62). The ABCD2 has been suggested as a refinement of the original score, with diabetes as a factor (36). In a statement from the American Stroke Association, it is recommended that patients be admitted to the hospital if they experience a transient ischemic attack in the preceding 72 hours and if the ABCD2 score is 3 or higher or if the score is 0 to 2 and there is uncertainty about whether diagnostic testing can be completed within two days as an outpatient (19).

One third to one half of patients with transient ischemic attacks will have a small ischemic lesion on MRI using DWI (19). A multi-center study of 4574 patients with early imaging after TIA found that DWI lesions can help identify a high-risk group (27). For patients with a DWI lesion, the 7-day rate of stroke was 7.1% versus 0.4% in patients without a DWI lesion (p< 0.0001). Some have advocated that the ABCD2 score plus early MRI can help with identifying low-risk patients who can be discharged home with outpatient investigations (27).

Clinical vignette

A 66-year-old man presented to the emergency room with the acute onset of expressive speech difficulty, which lasted for 20 minutes and then resolved. The patient and his family did not notice weakness, loss of consciousness, or seizure activity. The past medical history was notable for diabetes mellitus and hypertension for 10 years each. Medical history was negative for coronary artery disease or peripheral vascular disease.

On examination, the patient was in sinus rhythm with a blood pressure of 150/80 mm Hg. His exam revealed intact speech, no facial weakness, no limb weakness, and flexor plantar responses. There was a left carotid bruit. ECG was normal.

Subsequent testing revealed 80% to 99% stenosis of the left internal carotid artery on duplex. This was confirmed as severe stenosis on MRA. MRI of the brain showed two small, deep corona radiata infarcts on the left side. Successful left carotid endarterectomy was performed two days after presentation.

Biological basis

Etiology and pathogenesis

Ischemia of the internal carotid artery territory and its branches via embolism, thrombosis, or hemodynamic insufficiency is the underlying basis for carotid transient ischemic attacks. Rarely, vasospasm may be responsible for the symptoms of transient monocular blindness (72).

The underlying pathology for the ischemia of transient ischemic attacks may be atherothrombotic, embolic, inflammatory, or hematologic. The primary process could reside in the small or large arteries of the brain (within the carotid territory), the heart, or a coagulation disorder in the blood (50; 52). The specific transient ischemic attack symptoms rarely distinguish among these possibilities, which must be identified or excluded through laboratory testing.

Atherosclerosis of the internal carotid artery can appear as early as 25 to 40 years of age. It is usually patchy or focal rather than diffuse, and most commonly occurs at the carotid bifurcation or 2 cm from the internal carotid artery origin. Intracranial lesions are more frequent in African Americans and Asians; the cavernous segment of the internal carotid artery is the most often affected downstream from the bifurcation.

Atherosclerosis may progress over months or remain static for years, even if severe. About one third of atherosclerotic lesions progress and one third of these become symptomatic (52). After endarterectomy, redevelopment of greater than 50% stenosis appears in 14 months in 19% of patients, whereas 9% develop greater than 80% stenoses. About one half of these patients become symptomatic a second time. In the first two years after surgery, the mechanism of restenosis is believed to be myointimal hyperplasia, whereas atherosclerosis is believed to be more prevalent in restenoses that develop after this period (18).

Atherosclerotic lesions may produce symptoms by a hemodynamic mechanism, when the residual lumen is restricted to less than 2 mm (08; 46). Occlusion usually results from thrombosis superimposed on atherosclerosis. A hemodynamic mechanism may logically explain brief, stereotyped, especially orthostatic transient ischemic attacks. The deficit vanishes as blood flow is restored. Carotid plaques from patients with symptomatic cervical lesions have been reported to have less collagen staining and greater matrix metalloproteinase activity compared to asymptomatic plaques (70).

Embolism can also occur as platelet-fibrin thrombi commonly superimpose themselves on the atheroma and may easily be washed downstream to occlude smaller arteries and produce symptoms. The presence of fresh thrombus in an endarterectomy specimen distinguished recently symptomatic patients, 80% of whom had thrombus, from patients with remote symptoms or asymptomatic patients in whom thrombus was uncommon (30% to 40%) (68). Ulceration with no thrombus and plaque hemorrhage did not distinguish these groups of patients.

Cardiac embolism leading to carotid transient ischemic attack most often arises from nonvalvular atrial fibrillation. Other causes include postmyocardial infarction wall motion disorder, aortic atherosclerosis, cardiomyopathy, mitral valve prolapse and other valve diseases, patent foramen ovale, calcified aortic disease especially during catheterization or valve procedures, endocarditis, valve prostheses, and myxoma (69).

Less common causes of transient ischemic attack include dissection, fibromuscular dysplasia, kinking, extracranial aneurysm, local tumor invasion of the carotid, radiation therapy accelerated atherosclerosis, and postendarterectomy restenosis. Also, primary thrombi may develop in hypercoagulable blood (29).

Finally, vasospasm has been reported to occur in the eye and cause transient monocular blindness. The vasospasm may be primary or secondary to another disease, such as temporal arteritis or cocaine abuse (45).

Differential diagnosis

Confusing conditions

In one study in which thousands of transient ischemic attacks were reported by patients through questionnaire, subsequent evaluation of the patients by a physician rejected most of them as not being transient ischemic attacks, but as peripheral neuropathy, psychoneuroses, Bell palsy, migraine, cerebral infarction with an examination that failed to detect residual signs, seizures, conversion disorders, and structural lesions of the orbit. Migraine and seizures are important alternatives to the diagnosis of transient ischemic attack.

In migraine, one half of the patients with neurologic accompaniments do not experience headache. A buildup in severity of symptoms and a migration, especially of scintillations, flashing lights, colors, and fortification spectra across the visual field strongly suggest the diagnosis of migraine. An anatomic march of symptom type, from visual symptoms to aphasia to hemiparesis, for example, and the benign recurrence of symptoms over years, with or without episodic headache also suggest migraine. Some physicians require exclusion of appropriately located atherosclerosis before offering the diagnosis of migraine.

In seizures, convulsive activity precedes or follows the paralysis. These patients usually have structural lesions causing seizures, no vascular risk factors, and a therapeutic response to anticonvulsants. As with migraine, patients with seizures have positive phenomena that may migrate and leave negative phenomena in their wake.

Structural lesions may produce transient ischemic attack-like symptoms via an unclear mechanism. Such lesions include tumors, subdural hematomas, aneurysms, amyloid angiopathy, multiple sclerosis, hypertensive encephalopathy, hypoglycemia, and hyperventilation (20).

Associated or underlying disorders

The most common associated conditions are underlying vascular risk factors such as hypertension, diabetes, hypercholesterolemia, and smoking. Common cardiac causes for transient ischemic attacks include atrial fibrillation, valvular heart disease, and decreased cardiac ejection fraction.

Diagnostic workup

	• Duplex ultrasonography is the most common test in order to assess for internal carotid artery stenosis.
	• CT angiography is being increasingly performed in the emergency department and has become a common diagnostic test for patients with carotid transient ischemic attacks.
	• For patients with unexplained carotid transient ischemic attacks, extended cardiac monitoring to check for atrial fibrillation may be useful.

Numerous noninvasive technologies capable of identifying carotid bifurcation atherosclerosis reveal a disease prevalence similar to that found with angiography. MR angiography and color duplex ultrasound frequently compete as the screening study of choice for carotid disease. These tests seek to identify severe stenosis, both to establish a mechanism for transient ischemic attack and to identify surgical candidates. The positive and negative predictive values for surgical disease (70% to 99% angiographic stenosis) for color duplex are 0.84 and 0.98, respectively, and for MR angiography 0.79 and 0.81, respectively. MR angiography often displayed a flow gap (zone of signal intensity loss due to slow flow) in patients with severe disease, giving a false impression of complete occlusion. Color duplex performed better at distinguishing severe stenosis from complete occlusion in this cohort (65). Other physicians support the use of MR angiography over duplex, citing its higher interobserver reliability, the fact that it is less operator-dependent, and the fact that the entire vessel is seen. Ultrasound is probably cheaper and more readily available than MR angiography (51). In a study of 167 patients, contrast-enhanced MRA was associated with a stenosis misclassification rate of 15% (67). There is increasing interest in CT angiography as well, and a study of 81 vessels found that CT angiography had high negative predictive value (37). In eight vessels where CT angiography indicated greater than 70% stenosis, however, only five out of eight (63%) were greater than 70% on angiography, suggesting a tendency for overestimation of stenosis. Use of PET using the FDG ligand can also identify “hot” carotids. With use of PET imaging, patients with carotid stenosis at elevated risk of stroke recurrence can be identified (39). Such information can potentially be used to guide timing of carotid revascularization.

A clear algorithm for the optimal noninvasive evaluation of patients with carotid stenosis is not currently available. Physicians tailor their approach depending on the strengths and weaknesses of individual laboratories at their particular institution.

Transcranial Doppler ultrasound can detect hemodynamic changes distal to a carotid stenosis, which help assess the severity of bifurcation stenosis, improving the selection of patients for angiography. Transcranial Doppler can also assess the severity of intracranial disease and can detect emboli distal to internal carotid artery or cardiac disease in patients with transient ischemic attack. Emboli are abnormally high-pitched unidirectional signals, less than 0.1 second in duration that appear randomly in the cardiac cycle and make an easily heard chirping sound (26).

CT or MRI of the brain is performed in patients with transient ischemic attack to rule out mass lesions. A focal hypodensity appropriately located for the symptoms of the transient ischemic attack is found in approximately 34% of patients, who are then considered to have had cerebral infarction with transient signs. Their transient ischemic attacks usually last longer than average and are more often embolic in origin (52). MRI with diffusion-weighted imaging may be especially useful in patients with transient ischemic attacks. A study of 42 patients who were imaged with diffusion-weighted imaging within three days of symptom onset found that 48% of patients had a conspicuous lesion (41). Of these, approximately one half had corresponding infarcts on follow-up MR imaging. Diffusion-weighted imaging in patients with transient ischemic attacks may also help clarify the ischemia localization and the symptom mechanism.

The fact that many transient ischemic attack patients will have an associated small infarct on imaging studies has led to a new definition of transient ischemic attack from the American Stroke Association (19). In an analysis of pooled data from 10 MRI studies that enrolled 818 patients, it was observed that an MRI lesion is present in about one third of patients with symptoms lasting less than six hours and one half of patients with symptom duration of 6 to 24 hours (19). Based on this observation, the suggested definition of transient ischemic attack is “a transient episode of neurologic dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction.”

High-resolution plaque imaging with MRI is being used occasionally to identify high risk carotid stenosis. A study of patients with 50% to 99% symptomatic stenosis found that patients with intraplaque hemorrhage on MRI had an increased risk for stroke (23% annual risk), whereas the stroke risk was very low (0.6%) for patients without intraplaque hemorrhage (24). It has also been observed that men have more frequent intraplaque hemorrhage compared to women.

In patients with normal or mildly diseased carotid arteries or those at high risk of suspected embolism, cardiac testing is initiated. Cardiac monitoring is performed when an arrhythmia is suspected, such as intermittent atrial fibrillation. Studies with CTA have found a higher frequency of thick plaques (> 5 mm) ipsilateral to cryptogenic stroke, raising the possibility of a link between the nonstenotic plaque and stroke (16).

In patients where carotid and cardiac tests are unrevealing, systemic and coagulation abnormalities that can cause transient ischemic attack are sought. Atherosclerotic disease of the intracranial vessels should also be considered. The physician may perform tests for antiphospholipid antibodies and other hypercoagulable states, perform toxic drug screening, and perform serological tests for vasculitis.

Management

	• All patients with carotid transient ischemic attacks should receive intensive medical therapy, incorporating antithrombotic therapy, statins, blood pressure control, and lifestyle modification.
	• Select patients with severe carotid stenosis will benefit from carotid revascularization.

Patients with greater than 70% carotid stenosis and a recent ipsilateral carotid transient ischemic attack should be treated surgically if the perioperative stroke and death rate is less than 6% (53). In the North American Symptomatic Carotid Endarterectomy Trial (NASCET), carotid endarterectomy reduced the ipsilateral stroke rate in patients with transient ischemic attack or stroke and 70% to 99% stenosis from 26% to 9% after two years follow-up (53). The beneficial effect was greater for more severe stenoses. Of note, patients in the North American Symptomatic Carotid Endarterectomy Trial had become symptomatic within the last four months, whereas those in the European trial became symptomatic in the last six months. If symptoms have been present for a longer period, optimal management has not been determined. For patients with 50% to 69% stenosis in the North American Symptomatic Carotid Endarterectomy Trial, there was a modest benefit from surgery (absolute risk reduction 1.3% per year) (04), but the benefit was heterogeneous. Women and patients with retinal ischemia did not derive benefit. Below 50%, there was no benefit seen in the North American Symptomatic Carotid Endarterectomy Trial. It should be noted that the degree of stenosis measured as percent stenosis is not strictly comparable across the two clinical trials mentioned above.

A combined analysis of the North American and European symptomatic endarterectomy studies also evaluated the outcome in patients with a collapsed distal internal carotid artery, an angiographic finding referred to as “near occlusion” or a carotid string sign. In these patients external carotid filling is more brisk, and the external carotid is larger than the collapsed internal carotid. The combined analysis found no benefit of surgery in patients with carotid near occlusion, with a 1.7% trend for recurrent stroke favoring medical treatment at five years (59).

Physicians must keep in mind that the perioperative complication rate at their institution may be higher than the less than 6% rate preselected by the North American Symptomatic Carotid Endarterectomy Trial (13). This information may dampen their enthusiasm for the procedure at their institution. Higher complication rates are seen in surgeons with low annual volumes, especially less than 10 endarterectomies per year (43).

The perioperative complication rate for carotid endarterectomy may be increased by certain clinical and angiographic variables. In one analysis, two or more of the following factors doubled the risk: age greater than 75 years, diastolic blood pressure greater than 110 mm/Hg, history of angina, performance of endarterectomy in preparation for coronary artery bypass grafting, thrombus in the internal carotid artery lumen, or a downstream siphon stenosis (49). In 16% of endarterectomies, angiography or ultrasound performed at the completion of the procedure detects a correctable problem such as a kink, flap, thrombus, or spasm. Immediate correction of these difficulties lowers the perioperative complication rate (18). An analysis from a Scandinavian registry found that endarterectomy can be safely performed within 2 weeks of the patient having received intravenous thrombolysis (58). This study found the stroke/death rate to be 3.5% for patients with surgery following thrombolysis.

The American Academy of Neurology has published a previous statement on carotid endarterectomy (14). The statement includes information from the pooled analysis mentioned above for symptomatic patients. The absolute benefit at 5 years is 16% for patients with 70% to 99% stenosis and 4.6% for patients with 50% to 69% stenosis (60). In the pooled analysis, men, patients enrolled in the trial within two weeks of their last symptomatic event, and patients above age 75 years showed greater benefit. There were relatively few patients in the multi-center trials above age 80 years; however, some caution is needed in this group.

For patients at increased risk for endarterectomy, the SAPPHIRE study compared carotid artery stenting with distal protection versus endarterectomy (73). About one-third of the 334 patients were symptomatic. In the total cohort, the primary endpoint (stroke, death, or myocardial infarction within 30 days plus ipsilateral stroke between days 31 through 365) occurred in 12.2% of the stent patients and 20.1% of the endarterectomy patients (p=0.05). For the symptomatic patients, there was no difference with the primary endpoint occurring in 16.8% of the stent patients and 16.5% of the endarterectomy patients (p=0.95). There was not a medically treated control group, so it is difficult to judge if either intervention was better than medical therapy alone. The Center for Medicare Services has approved the reimbursement of carotid stenting for symptomatic patients with 70% to 99% stenosis who are at increased risk for endarterectomy.

Three European studies have compared carotid endarterectomy to carotid artery stenting (11). In a pooled analysis of these trials, within 120 days of study entry there was an increased risk of stroke or death in those patients assigned to carotid artery stenting (8.9%) compared to those who received carotid endarterectomy (5.8%, hazard ratio 1.53, p=0.0006). However, a significant interaction was noted with age. In patients 70 years of age or older, the risk with carotid artery stenting was magnified (12.0% with carotid artery stenting, 5.9% with carotid endarterectomy, HR 2.04). However, no difference was noted in the 120-day risk of stroke or death in patients younger than 70 years of age (5.8% carotid artery stenting vs. 5.7% carotid endarterectomy).

For conventional risk subjects, the Carotid Revascularization Endarterectomy vs. Stent Trial (CREST) results were reported (31; 09). The trial included both symptomatic and asymptomatic subjects. A total of 1321 symptomatic patients were enrolled with either more than 50% stenosis on angiography or more than 70% stenosis on ultrasound. Patients were required to have had an ipsilateral transient ischemic attack or nondisabling stroke within 6 months of study entry.

Patients were followed for the primary endpoint of stroke, myocardial infarction, or death within 30 days and ipsilateral stroke after 30 days. Within the 30-day periprocedure period, the primary endpoint did not differ between the carotid artery stenting and carotid endarterectomy groups (09). The rate was 6.7% in the carotid artery stenting group and 5.4% in the carotid endarterectomy group (HR 1.26, p=0.30). However, some have criticized the inclusion of myocardial infarction in the primary endpoint (17). If myocardial infarction is removed and the traditional stroke or death endpoint is used, then symptomatic patients did better with carotid endarterectomy (6.0% stroke/death with carotid artery stenting, 3.2% with carotid endarterectomy, HR 1.89, p=0.02). The CREST investigators also reported a higher event rate with carotid artery stenting compared to carotid endarterectomy in patients more than 70 years old (71). For the primary endpoint, there was 1.77 times increase in the rate of the primary endpoint for each 10-year increment in age. At the current time in North America, carotid artery stenting has not been approved for conventional risk patients. Some of the differences between the European studies and CREST and other issues pertaining to carotid revascularization are highlighted in a review (56).

A newer revascularization option is transcarotid artery revascularization (TCAR), in which direct access is achieved in the common carotid artery and flow reversal is instituted from the internal carotid artery to the femoral vein. One advantage of TCAR compared to transfemoral stenting is that TCAR avoids the aorta, which can be a source of embolic debris and periprocedural stroke. Analysis of a large national registry found a lower complication rate with TCAR compared to transferal stenting (64). A multicenter register also evaluated TCAR. The single arm ROADSTER 2 registry found a 5.0% stroke/death rate in symptomatic patients and a 1.4% rate in asymptomatic patients (38). Registry data showed that 1-year outcomes were similar between TCAR and carotid endarterectomy, but the rate of complete data availability was limited (44). There is not randomized trial information available on TCAR, and as a result, recent American Heart Association/American Stroke Association guidelines felt that the utility of TCAR in symptomatic patients is not well established (42).

Guidelines recommend early (less than 7 days) carotid revascularization for patients with carotid transient ischemic attack or nondisabling stroke (55). However, in actual practice, only a minority of patients receive early revascularization. In a study of 4138 patients, only 11% to 14% received the procedure within seven days of symptoms (57). In this same analysis, endarterectomy appears to provide better results than stenting, with a 1.3% rate of stroke/death with endarterectomy and an 8.3% risk of stroke/death with stenting.

The mechanism of stroke following carotid revascularization procedures is diverse. Analysis of 85 patients with postoperative stroke in a clinical trial found the following mechanisms: 14 carotid-embolic cases, 20 hemodynamic cases, 15 patients with occlusion of the carotid, nine hyperperfusion cases, five cardioembolic patients, and three patients with multiple causes (32).

In patients with complete occlusion of the internal carotid artery, external carotid collaterals commonly reconstitute the ophthalmic artery and intracerebral vessels. Stenosis and ulcers in the external carotid or internal carotid cul-de-sac in such patients can cause eye and brain symptoms. Two thirds of these patients have transient monocular blindness as the indication for surgery. External carotid endarterectomy can be effective for these embolic sources at the external carotid origin (63).

Patients with noncardioembolic stroke or transient ischemic attack should be treated with antiplatelet therapy, such as aspirin, clopidogrel, or low-dose aspirin and dipyridamole (42). In addition, aggressive risk factor modification is important. This would include smoking cessation and treatment of hypertension and diabetes. Anticoagulation is employed in patients with sources of recurrent cardiac embolism. Dietary modification and regular physical activity are also recommended for patients with transient ischemic attack (42).

For patients with severe carotid stenosis awaiting surgery, early use of both aspirin and clopidogrel has been associated with a reduced rate of microemboli and lower rate of recurrent stroke (05).

In the 2021 American Stroke Association (ASA) stroke prevention update, a few items are noteworthy. First, aspirin alone (50 to 325 mg), clopidogrel, or aspirin plus extended-release dipyridamole are all acceptable for initial therapy (42). Administration of a statin with intensive lipid-lowering effects is recommended in patients with an atherosclerotic stroke or transient ischemic attack, even in the absence of overt ischemic heart disease (47). The ASA document further comments that for patients with an atherosclerotic stroke or transient ischemic attack, and without known coronary heart disease, it is reasonable to target a reduction of LDL of at least 50% or an LDL of less than 70 mg/dl. For patients over the age of 70, carotid endarterectomy is preferred over carotid stenting. Finally, it is worth noting that the NASCET data are 30 years old, and new trials are needed to compare intensive medical therapy with carotid revascularization (12).

The POINT study (Platelet Oriented Inhibition in New TIA and minor ischemic stroke, NCT00991029) evaluated the use of dual antiplatelet therapy (DAPT) for 90 days in patients with high-risk transient ischemic attacks or minor strokes (34). It enrolled patients with an ABCD score of 4 or greater or NIH stroke scale score of 3 or less who could be treated within 12 hours. Subjects received either aspirin alone or aspirin plus clopidogrel (600 mg loading dose followed by 75 mg per day) for a 90-day treatment period, with the primary endpoint being stroke, myocardial infarction, or vascular death. The primary endpoint was reduced by 25% in patients who received DAPT with aspirin and clopidogrel. Further analysis stratified by duration of treatment suggests that three weeks of DAPT appears to be the optimal treatment duration.

There also appears to be benefit in using DAPT for patients presenting within 72 hours of a transient ischemic attack or minor stroke. A study from China (INSPIRES) compared single antiplatelet therapy with aspirin with DAPT combining aspirin and clopidogrel (25). Patients were enrolled with a high-risk transient ischemic attack or minor stroke with an NIH stroke scale score of 5 or less. Trial participants were also required to have more than 50% stenosis of an ipsilateral vessel. Over the study period, 6100 patients were enrolled. The stroke rate within 90 days was 7.3% with DAPT versus 9.2% with aspirin alone, a significant difference. Moderate to severe bleeding occurred in 0.9% of the DAPT group and 0.4% of the aspirin group.

Another antiplatelet option for patients with carotid transient ischemic attacks is ticagrelor. In the THALES trial, patients with minor stroke or high risk transient ischemic attack who were evaluated within 24 hours were assigned to either ticagrelor (180 mg loading dose, then 90 mg bid) plus aspirin or aspirin alone. Over 11,000 patients were enrolled and the ischemic stroke rate within 30 days was 5.0% with aspirin plus ticagrelor versus 6.3% with aspirin alone (33). Serious bleeding was higher with dual antiplatelet therapy (0.5% vs. 0.1%). In a subgroup analysis of patients with atherosclerotic stroke, the benefit of aspirin plus ticagrelor was greater (8.1% vs. 10.9%, 27% relative reduction) (01).

Outcomes

With modern medical therapy, the risk of stroke following a transient ischemic attack has decreased. A multicenter registry analyzed patients who were evaluated following a transient ischemic attack (02). The 1-year risk of stroke was 5.1%; this is lower than the 10% to 15% rate observed in earlier decades. Patients with large vessel atherosclerosis and those with multiple lesions on diffusion-weighted imaging were at increased risk for stroke.

References

01: Amarenco P, Denison H, Evans SR, et al. Ticagrelor added to aspirin in acute nonsevere ischemic stroke or transient ischemic attack of atherosclerotic origin. Stroke 2020;51(12):3504-13. PMID 33198608
02: Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 2016;374(16):1533-42. PMID 27096581
03: Amarenco P, Lavallee PC, Monteiro Tavares L, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med 2018;378:2182-90. PMID 297667771
04: Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339(20):1415-25. PMID 9811916
05: Batchelder A, Hunter J, Cairns V, et al. Dual antiplatelet therapy prior to expedited surgery reduces recurrent events prior to surgery without significantly increasing peri-operative bleeding complications. Eur J Vasc Endovasc Surg 2015;50(4):412-9. PMID 26283034
06: Benavente OR, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid artery stenosis. N Engl J Med 2001;345:1084-90. PMID 11596587
07: Benavente OR, Streifler JY, Harbison JW, Eliasziw M, Hachinski VC, Barnett HJ. Differences between retinal TIA and hemispheric TIA of carotid stenosis origin: observations from NASCET. Neurology 1992;42(Suppl 3):341.
08: Brice JG, Dowsett DG, Lowe RD. Haemodynamic effects of carotid artery stenosis. Br Med J 1964;2:1363. PMID 14208203
09: Brott, TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23. PMID 20505173
10: Caplan LR. The frontal artery sign--a bedside indicator of internal carotid occlusive disease. N Engl J Med 1973;288:1008. PMID 4696236
11: Carotid Stenting Trialists Collaboration, Bonati LH, Dobson J, et al. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet 2010;376(9746):1062-73. PMID 20832852
12: Chaturvedi S. Aggressive medical therapy alone is adequate in certain patients with severe symptomatic stenosis. Stroke 2013;44(10):2957-8. PMID 23943215
13: Chaturvedi S, Aggarwal R, Murugappan A. Results of carotid endarterectomy with prospective neurologist follow-up. Neurology 2000;55:769-72. PMID 10993994
14: Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy – an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005;65(6):794-801. PMID 16186516
15: Clark TG, Murphy MF, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in “low risk” patients with a non-recent transient ischemic attack. J Neurol Neurosurg Psychiatry 2003;74:577-80. PMID 12700296
16: Coutinho JM, Derkatch S, Potvin AR, et al. Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke. Neurology 2016;87(7):665-72. PMID 27412144
17: Davis SM, Donnan GA. Carotid-artery stenting in stroke prevention. N Engl J Med 2010;363:80-2. PMID 20505174
18: Donaldson MC, Ivarsson BL, Mannick JA, Whittemore AD. Impact of completion angiography on operative conduct and results of carotid endarterectomy. Ann Surg 1993;217:682-7. PMID 8507114
19: Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke 2009;40:2276-93. PMID 19423857
20: Feldmann E, Wilterdink JL. The symptoms of transient cerebral ischemic attacks. Semin Neurol 1991;11:135-45. PMID 1925129
21: Fisher M. Occlusion of the internal carotid artery. Arch Neurol Psychiatry 1951a;65:346-77. PMID 14810266
22: Fisher M. Transient monocular blindness associated with hemiplegia. Trans Am Neurol Assoc 1951b;76:154-8. PMID 14913612
23: Flaherty ML, Brown RD. The epidemiology of transient ischemic attacks. In: Chaturvedi S, Levine SR, editors. Transient ischemic attacks. Blackwell, 2004.
24: Hosseini AA, Kandiyil N, MacSweeney ST, Altaf N, Auer DP. Carotid plaque hemorrhage on magnetic resonance imaging strongly predicts recurrent ischemia and stroke. Ann Neurol 2013;73(6):774-84. PMID 23463579
25: Gao F, Chen W, Pan Y, et al. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med 2023;389(26):2413-24. PMID 38157499
26: Georgiadis D, Grosset DG, Lees KR. Transhemispheric passage of microemboli in patients with unilateral internal carotid occlusion. Stroke 1993;24:1664-6. PMID 8236339
27: Giles MF, Albers GW, Amarenco P, et al. Early stroke risk in ABCD2 score performance in tissue- vs time-based TIA: a multicenter study. Neurology 2011;77(13):1222-8. PMID 21865578
28: Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischemic attacks. J Neurol Neurosurg Psychiatry 1991;54:793-802. PMID 1955898
29: Hart RG, Easton JD. Dissections of cervical and cerebral arteries. Neurol Clin North Am 1983;1:155. PMID 6680158
30: Hill MD, Yiannakoulias N, Jeerakathil T, et al. The high risk of stroke immediately after transient ischemic attack. Neurology 2004;62:2015-20. PMID 15184607
31: Hobson RW. CREST: background, design, and current status. Semin Vasc Surg 2000;13:139-43. PMID 10879554
32: Hulbers A, Calvet D, Kennedy F, et al. Mechanism of procedural stroke following carotid endarterectomy or carotid artery stenting within the International Carotid Stenting Study (ICSS) randomised trial. Eur J Vasc Endovasc Surg 2015;50(3):281-8. PMID 26160210
33: Johnston SC, Amarenco P, Denison H, et al. Ticagelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 2020;383:207-17. PMID 32668111
34: Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. New Engl J Med 2018;379(3):215-25. PMID 29766750
35: Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901-6. PMID 11147987
36: Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369(9558):283-92. PMID 17258668
37: Josephson SA, Bryant SO, Mak HK, Johnston SC, Dillon WP, Smith WS. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology 2004;63:457-60. PMID 15304575
38: Kashyap VS, Schneider PA, Foteh M, et al. Early outcomes in the ROADSTER 2 study of transcarotid artery revascularization in patients with significant carotid artery stenosis. Stroke 2020;51(9):2620-9. PMID 32811386
39: Kelly PJ, Campos-Renom P, Giannotti N, et al. Carotid plaque inflammation imaged by F-fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke. Stroke 2019;50(7):1766-73. PMID 31167623
40: Kernan WN, Horwitz RI, Brass LM, Viscoli CM, Taylor KJ. A prognostic system for transient ischemia or minor stroke. Ann Intern Med 1991;114:552-7. PMID 2001088
41: Kidwell CS, Alger J, Di Salle F, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999;30:1174-80. PMID 10356095
42: Kleindorfer D, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2021;52(7):e364-e467. PMID 34024117
43: Kumamaru H, Jalbert JJ, Nguyen LL, et al. Surgeon case volume and 30-day mortality after carotid endarterectomy among contemporary Medicare beneficiaries: before and after national coverage determination for carotid artery stenting. Stroke 2015;46(5):1288-94. PMID 25791713
44: Liang P, Cronenwett JL, Secemsky EA, et al. Risk of stroke, death, and myocardial infarction following transcarotid artery revascularization vs carotid endarterectomy in patients with standard surgical risk. JAMA Neurol 2023;80(5):437-44. PMID 36939697
45: Libman RB, Masters SR, de Paola A, Mohr JP. Transient monocular blindness associated with cocaine abuse. Neurology 1993;43:228-9. PMID 8423897
46: Lusby RJ, Ferrell LD, Ehrenfeld WK, Stoney RJ, Wylie EJ. Carotid plaque hemorrhage: its role in reproduction of cerebral ischemia. Arch Surg 1982;117:1479. PMID 6182861
47: Mac Grory B, Yahhi S, Cordonnier C, Sposato LA, Romano JG, Chaturvedi S. Advances in recurrent stroke prevention: focus on antithrombotic therapies. Circ Res 2022;130(8):1075-94. PMID 35420910
48: Marshall J, Meadows S. The natural history of amaurosis fugax. Brain 1968;91:419. PMID 5723016
49: McCrory DC, Goldstein LB, Samsa GP, et al. Predicting complications of endarterectomy. Stroke 1993;24:1285-91. PMID 8362419
50: McGill HG, Strong JP. Natural history of human atherosclerotic lesions. In: Sandler M, Bourne GH, editor. Atherosclerosis and its origin. Orlando: Academic Pr, 1963:39.
51: Mittl RL, Broderick M, Carpenter JP, et al. Blinded-reader comparison of magnetic resonance angiography and duplex ultrasonography for carotid artery bifurcation stenosis. Stroke 1994;25:4-10. PMID 8266380
52: Mohr JP, Gautier JC, Pessin MS. Internal carotid artery disease. In: Barnett HJ, Mohr JP, Stein B, Yatsu FM, editors. Stroke. New York: Churchill Livingstone, 1992:285-335.
53: North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53. PMID 1852179
54: O'Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol 1992;76:660-2. PMID 1477040
55: Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49(3):e46-e110. PMID 29367334
56: Rajamani K, Chaturvedi S. Stroke prevention-surgical and interventional approaches to carotid stenosis. Neurotherapeutics 2011;8(3):503-14. PMID 21647764
57: Rantner B, Kollerits B, Roubin GS, et al. Early endarterectomy carries a lower procedural risk than early stenting in patients with symptomatic stenosis of the internal carotid artery: results from 4 randomized controlled trials. Stroke 2017;48(6):1580-7. PMID 28455318
58: Rathenborg LK, Venermo M, Troëng T, et al. Editor’s choice - Safety of carotid endarterectomy after intravenous thrombolysis for acute ischemic stroke: a case-controlled multicentre registry study. Eur J Vasc Endovasc Surg 2014;48(6):620-5. PMID 25443523
59: Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361(9352):107-16. PMID 12531577
60: Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-24. PMID 15043958
61: Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007;370(9596):1432-42. PMID 17928046
62: Rothwell PM, Giles MF, Flossman E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischemic attack. Lancet 2005;366:29-36. PMID 15993230
63: Rush DS, Holloway WO, Fogartie JE, Fine JG, Haynes JL. The safety, efficacy and durability of external carotid endarterectomy. J Vasc Surg 1992;16:407-13. PMID 1522644
64: Schermerhorn ML, Liang P, Eldrup-Jorgensen J, et al. Association of transcarotid artery revascularization vs transfemoral carotid artery stenting with stroke or death among patients with carotid artery stenosis. JAMA 2019;322(23):2313-22. PMID 31846015
65: Sitzer M, Furst G, Fischer H, et al. Between-method correlation in quantifying internal carotid stenosis. Stroke 1993;24:1513-8. PMID 8378955
66: Stromberg S, Nordanstig A, Bentzel T, Österberg K, Bergström GM, et al. Risk of early recurrent stroke in symptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2015;49(2):137-44. PMID 25548062
67: U-King-Im JM, Trivedi RA, Graves MJ, et al. Contrast-enhanced MR angiography for carotid disease. Neurology 2004;62:1282-90. PMID 15111663
68: Van Damme H, Demoulin JC, Zicot M, Creemers E, Trotteur G, Limet R. Pathological aspects of carotid plaques. Surgical and clinical significance. J Cardiovasc Surg 1992;33:46-53. PMID 1544996
69: van Rhee F, Blecher TE, DeLepeleire KA, Galloway NR. Bilateral retinal artery occlusion due to mitral valve prolapse. Br J Ophthalmol 1991;75:436-7. PMID 1854701
70: Verhoeven B, Hellings WE, Moll FL, et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg 2005;42:1075-81. PMID 16376194
71: Voeks JH, Howard G, Roubin GS, et al. Age and outcomes after carotid stenting and endarterectomy. Stroke 2011;42(12):3484-90. PMID 21980205
72: Winterkorn JM, Kupersmith MJ, Wirtschafter JD, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993;329:396-8. PMID 8326973
73: Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351(15):1493-501. PMID 15470212

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Seemant Chaturvedi MD

Dr. Chaturvedi of University of Maryland has no relevant financial relationships to disclose.
See Profile

Editor

Steven R Levine MD

Dr. Levine of the SUNY Health Science Center at Brooklyn has no relevant financial relationships to disclose.
See Profile

Former Authors

Edward Feldmann MD (original author)

Patient Profile

Age range of presentation: 19 to 65+ years
Sex preponderance: male=female
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Other specified transient cerebral ischemias: 435.8
ICD-10: Other transient cerebral ischaemic attacks and related syndromes: G45.8

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

TIAs (carotid)

Associated Disorders

Carotid stenosis
Cardiac embolism
Atrial fibrillation
Hypercoagulability
Cerebral infarction
- Valvular heart disease

Differential Diagnosis

peripheral neuropathy
psychoneuroses
Bell palsy
migraine
cerebral infarction
- seizures
- conversion
- structural lesions to the orbit
- tumors
- subdural hematomas
- aneurysms
- amyloid angiopathy
- multiple sclerosis
- hypertensive encephalopathy
- hypoglycemia
- hyperventilation

Also Relevant

Amaurosis fugax
Carotid bruit
Headache associated with ischemic cerebrovascular disease
Ischemic stroke
Stroke therapy
- Vertebrobasilar TIA

TIAs (carotid)

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Outcomes

Special considerations

Pregnancy

Anesthesia

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Ischemic stroke

Cerebral embolism

Hormonal contraception and stroke

Antiphospholipid antibody syndrome

Sleep, stroke, and vascular dementia

Vein of Galen malformations

Patent foramen ovale

Neuroimaging in acute stroke

This is an article preview.
Start a Free Account
to access the full version.